Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells

Author： Mehta R.R.   Hawthorne M.E.   Graves J.M.   Mehta R.G.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.6, 1998-05, pp. : 902-907

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Chronic Administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in Rats on Vitamin A Metabolism in the Eye

By Lewis K.C.   Zech L.A.   Phang J.M.  

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1803-1808

Elsevier

Access to resources Recommend Favorite

Suppression of pRB expression in normal human mammary epithelial cells is associated with resistance to all-trans-retinoic acid but not N-(4-hydroxylphenyl)-retinamide

By Dietze E.C.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

Human transplacental passage of the retinoid fenretinide (4HPR)

By Formelli F.   De Palo G.   Costa A.   Veronesi U.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 428-429

Elsevier

Access to resources Recommend Favorite

Chlorophyllin e4 is a novel photosensitizer against human bladder cancer cells

By Li Bin   Wu Zhiming   Li Wenzhi   Jia Guojin   Lu Jiancheng   Fang Jie   Chen Gang  

Oncology Reports, Vol. 27, Iss. 5, 2012-05 ,pp. : 1455-1460

Spandidos Publications

Access to resources Recommend Favorite

Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient mice

By            

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 55-64

Spandidos Publications

Access to resources Recommend Favorite